MCL1 and gastric cancer: Additionally, miR-302b, miR-320, and miR-512-5p have been validated to target MCL1 and regulate cancer progression and apoptosis in malignant pleural mesothelioma [120], cervical cancer [121], and gastric cancer [122], respectively.